SIBUTRAMINE

作品数:13被引量:31H指数:4
导出分析报告
相关作者:黄伟雄李少霞杜达安吴昊更多>>
相关机构:广东省疾病预防控制中心中国农业大学克诺尔有限公司更多>>
相关期刊:《World Journal of Acupuncture-Moxibustion》《Journal of Pharmaceutical Analysis》《American Journal of Analytical Chemistry》《Acta Pharmacologica Sinica》更多>>
相关基金:河北省中医药管理局科研计划项目河北省科技厅科研项目更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Gold immunochromatographic assay for simultaneous detection of sibutramine and sildenafil in slimming tea and coffee被引量:9
《Science China Materials》2020年第4期654-659,共6页Steven Suryoprabowo Liqiang Liu Hua Kuang Gang Cui Chuanlai Xu 
financially supported by the National Key R&D Program of China (2016YFD0401101 and KYCX18_1756)
Weight gain and obesity are worldwide problems prompting a search for many health supplements that provide benefits such as revitalization,skin-beautification,visual improvement,and slimming effects,mainly based on he...
关键词:高特异性 减肥茶 西地那非 西布曲明 胶体金免疫层析 实验室制备 金纳米粒子 咖啡 
Determination of Sibutramine and Its <i>N</i>-Desmethyl Metabolites in Human Plasma Using HPLC Coupled with Tandem Mass Spectroscopy
《American Journal of Analytical Chemistry》2014年第9期589-597,共9页Mohammad Al-Bayari 
The following article has been retracted due to the investigation of complaints received against it. The Editorial Board found that there are conflicts of interests between the authors and their organization. The scie...
关键词:SIBUTRAMINE HPLC-MS/MS Plasma ESI Source Positive Ion MODE MRM MODE 
Quantification of sibutramine and its two metabolites in human plasma by LC-ESI-MS/MS and its application in a bioequivalence study被引量:6
《Journal of Pharmaceutical Analysis》2012年第4期249-257,共9页Venkata Suresh Ponnuru B.R.Challa RamaRao Nadendla 
Obesity can be considered as a chronic illness of epidemic proportion and its incidents have increased exponentially in recent years.The use of anti-obesity drugs such as sibutramine is somewhat helpful.There is a nee...
关键词:LC–ESI-MS/MS SIBUTRAMINE Human plasma BIOEQUIVALENCE Pharmacokinetic study 
Laboratory animals as surrogate models of human )besity被引量:1
《Acta Pharmacologica Sinica》2012年第2期173-181,共9页Cecilia NILSSONt Kirsten RAUN Fei-fei YAN Marianne O LARSEN Mads TANG-CHRISTENSEN 
Obesity and obesity-related metabolic diseases represent a growing socioeconomic problem throughout the world. Great emphasis has been put on establishing treatments for this condition, including pharmacological inter...
关键词:OBESITY animal models SIBUTRAMINE LIRAGLUTIDE KK-Ay mice ob/ob mice Zucker rat diet-induced obesity models 
Effects of liraglutide and sibutramine on food intake, palatability, body weight and glucose tolerance in the gubra DlO-rats被引量:6
《Acta Pharmacologica Sinica》2012年第2期194-200,共7页Gitte HANSEN Jacob JELSlNG Niels VRANG 
Aim: To validate the gubra DlO-rats as a useful animal model of human obesity. Methods- The gubra diet-induced obesity (DIO) rat model was based on male Sprague-Dawley rats with ad libitum access to regular chow an...
关键词:obesity diet-induced obese rats food preference glucose tolerance glucagon-like peptide-1 (GLP-1) 5-hydroxytryptamine(5-HT) SIBUTRAMINE LIRAGLUTIDE 
Rise and fall of anti-obesity drugs被引量:7
《World Journal of Diabetes》2011年第2期19-23,共5页Bernard MY Cheung 
Although it is not generally a life-threatening disease,obesity is becoming a major health problem worldwide.It can be controlled by means of drugs,and,consequently,these are required to be safe as well as effective.I...
关键词:OBESITY ANTI-OBESITY DRUGS SIBUTRAMINE RIMONABANT ORLISTAT 
Combination drug treatment in patients with non-alcoholic fatty liver disease被引量:2
《World Journal of Hepatology》2010年第4期139-142,共4页Theodosios D Filippatos Moses S Elisaf 
Non-alcoholic fatty liver disease (NAFLD) includes simple steatosis, a benign condition, and non-alcoholic steatohepatitis, a condition that beyond TG accumulation also includes necroinflammation and fibrosis. An asso...
关键词:Non-alcoholic fatty liver disease Non-alcoholic steatohepatitis Treatment ORLISTAT SIBUTRAMINE FENOFIBRATE EZETIMIBE Weight loss 
Combination drug treatment in obese diabetic patients
《World Journal of Diabetes》2010年第1期8-11,共4页Theodosios D Filippatos Moses S Elisaf 
Drug combinations that include antiobesity drugs(such as orlistat and sibutramine) and target cardiovascular disease(CVD) risk factors may be a good approach to patients with type 2 diabetes and/or metabolic syndrome(...
关键词:Diabetes METABOLIC syndrome ORLISTAT SIBUTRAMINE FENOFIBRATE EZETIMIBE Weight loss 
西布曲明(sibutramine)在澳大利亚使用后收到的ADR报告
《药物流行病学杂志》2008年第1期39-39,共1页
根据澳大利亚药物不良反应顾问委员会(ADRAC)统计,自2002年1月开始使用西布曲明减肥药至今,已收到138份ADR报告(计404例),其中属于神经系统ADR66例(包括头痛20例,眩晕14例,5-HT综合征5例等);精神性ADR50例(包括抑郁症12例...
关键词:ADR报告 澳大利亚 西布曲明 5-HT综合征 药物不良反应 顾问委员会 神经系统 攻击行为 
EFFECT OF ACUPUNCTURE ON HYPERLEPTINAEMIA AND HYPERINSULINEMIA IN OBESITY RATS
《World Journal of Acupuncture-Moxibustion》2005年第2期21-24,共4页王雪敏 王少锦 康锁彬 田新乐 葛建军 孙立虹 
ThisresearchissubsidizedbyHebeiBureauofScienceandTechnology(0427610D9)andHebeiAdministrationofTCM(2003048)
Objective: To observe the effect of acupuncture on hyperleptinaemia and hyperinsulinemia for studying its underlying mechanism about anti-obesity and reducing blood lipid in obesity rats. Methods: A total of 80 SD rat...
关键词:Obesity Acupuncture therapy Serum leptin and insulin Sibutramine 
检索报告 对象比较 聚类工具 使用帮助 返回顶部